NASDAQ · POM
POMDOCTOR LIMITED financials
$0.9300+2.20%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 |
|---|---|
| Revenue | $57.2M |
| Gross profit | $7.5M |
| Gross margin | 13.1% |
| Operating income | -$17.0M |
| Net income | -$30.4M |
| Net margin | −53.2% |
| Diluted EPS | $-56.50 |
| EBITDA | -$16.6M |
| Operating cash flow | -$21.2M |
| Free cash flow | -$21.5M |
| Diluted shares | 0.5M |
Balance sheet
| Period end | Dec 31 |
|---|---|
| Cash & equivalents | $1.4M |
| Short-term investments | $0.00 |
| Total debt | $64.6M |
| Total assets | $15.4M |
| Total liabilities | $84.2M |
| Shareholders' equity | -$68.8M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology